Walleye Capital’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Walleye Capital’s Portfolio BIOSW Stock Details BIOSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-175,889	Closed	-$9.85K	–	5803
2023 Q3	$9.85K	Buy	175,889 +80,000	+83%	+$9.57K	﹤0.01%	4487
2023 Q2	$14.1K	Buy	95,889 +63,996	+201%	+$6.62K	﹤0.01%	3864
2023 Q1	$3.03K	Hold	31,893	–	–	﹤0.01%	3722
2022 Q4	$3.19K	Hold	31,893	–	–	﹤0.01%	2924
2022 Q3	$3K	Hold	31,893	–	–	﹤0.01%	3027
2022 Q2	$4K	Hold	31,893	–	–	﹤0.01%	2168
2022 Q1	$7K	Buy	+31,893	New	+$8.28K	﹤0.01%	2162

Walleye Capital's BIOSW Position: Q4 2023 in Review

Walleye Capital sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2023, closing a stake of 175,889 shares — an estimated $9.85K sold.

Walleye Capital first reported a position in BIOSW in Q1 2022 and held it in 7 quarters. The position peaked at $14.1K in Q2 2023. 0 funds tracked by Wall St. Rank hold BIOSW as of Q4 2023.

Walleye Capital reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
Walleye Capital sold 175,889 BioPlus Acquisition Corp. Warrants shares in Q4 2023, an estimated $9.85K.
Walleye Capital first reported a position in BioPlus Acquisition Corp. Warrants in Q1 2022 and held it in 7 quarters.
Walleye Capital's BioPlus Acquisition Corp. Warrants position peaked at $14.1K in Q2 2023.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2023.

Based on Walleye Capital's 13F filing for Q4 2023, filed 14 Feb 2024.